Katerina K Naka
Katerina K Naka is an expert in Cardiology at University Hospital of Ioannina (Greece). Katerina K Naka has authored 282 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 822 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Biochemistry - Public Health - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 282
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Investigating the Role of Tetranectin in Ischaemic Heart Disease and Heart Failure. PMID 42893067 — heart diseases, myocardial infarction, fibrosis, heart failure, heart, biomarkers, research, fibroblasts, plasma | Ulster Med J | 2026 | 0 |
| Prospective Evaluation of Quality-of-Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION-HF 12-Month Results. PMID 42701883 — diabetes mellitus, quality of life, mortality, hospitalization, heart failure, cardiology, heart failure, systolic, therapeutics | Clin Cardiol | 2026 | 0 |
| 2026 ESC Guidelines for the management of heart failure. PMID 42661420 — heart failure, heart, cardiology | Eur Heart J Top journal | 2026 | 27 |
| Epidemiology and clinical features of acute coronary syndrome patients in selected hospitals in Greece: the CALLINICUS-Hellas registry. PMID 42489582 — registries, epidemiology, myocardial infarction, acute coronary syndrome, st elevation myocardial infarction, sex | Acta Cardiol | 2026 | 3 |
| Association Between Myocardial Infarction and Depression: Bidirectional Links and Shared Risk Pathways-A Systematic Review and Meta-Analysis. PMID 41967088 — depression, comorbidity, myocardial infarction, stress, physiological, cardiovascular diseases, stress disorders, traumatic, sex, risk factors, heart disease risk factors | Eur J Prev Cardiol | 2026 | 0 |
Clinical Studies 8
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| EASi PROTKT A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes high blood pressure and cardiovascular disease 2025-521188-11-00 — diabetes mellitus, hypertension, safety, blood, cardiovascular diseases, blood pressure, diabetes mellitus, type 2 | Phase 3 | Recruiting | 2025 |
| Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease NCT06081205 — mortality, embolism, myocardial infarction, shock, cardiogenic, heart failure, heart, cardiovascular diseases, hospital mortality, informed consent, acute coronary syndrome, pulmonary embolism, intensive care units | N/A | Recruiting | 2023 |
| Novel Echocardiographic Biomarkers Assessing the Myocardial Work in Heart Failure NCT05573997 — heart valve diseases, heart diseases, laboratories, hospitalization, heart failure, heart, cardiovascular diseases, phenotype, biomarkers, work, echocardiography, heart valves | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map